Skip to content
NKCELLThe NK guide

Tests & terms

How Is NK Cell Activity Measured?

NK cell activity is a family of laboratory readouts, not one number. CD107a degranulation, K562 killing assays and chromium release answer different questions, and their results should not be swapped.

An NK cell activity test does not produce one universal measure. A CD107a result can show that natural killer (NK) cells are releasing cytotoxic granules, while a K562 killing assay asks whether target cells actually die. Those are related events, but one does not stand in for the other. A sample can look active on a degranulation marker and still need a separate lysis assay to ask whether killing occurred. That is the core distinction behind most NK cell activity measurements.

One label, several laboratory questions

NK cells are immune cells studied for their cytotoxic and cytokine-producing functions. In a lab, activity is an umbrella word. It may refer to degranulation, cytokine production, or the death of target cells. Flow cytometry—a method that measures markers on individual cells—is used in several of these assays. The methods article Functional Analysis of Human NK cells by Flow Cytometry describes CD107a degranulation, K562 or target-cell stimulation, and cytokine readouts. The same article makes a boundary explicit: degranulation is not the same as target-cell lysis.

CD107a: a release signal, not a kill count

CD107a is a surface marker that appears when cytotoxic granules fuse with the cell membrane. In an NK cell assay, detecting CD107a by flow cytometry is a way to ask whether degranulation has been triggered after stimulation. It is a useful readout because granule release is part of the killing pathway. But the methods article is clear that the presence of CD107a does not by itself prove that target cells have been lysed. Put plainly: CD107a answers whether the release machinery engaged. It does not answer how many target cells died.

K562 lysis: counting dead target cells under assay conditions

A cytotoxicity assay takes a different route. The flow-cytometry cytotoxicity method titled A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity describes CFSE-labeled K562 target cells, dead-cell staining, controls, and effector-to-target ratios. In simple terms, target cells are labeled, exposed to NK cells, and then checked for death. The effector-to-target ratio is the number of NK cells relative to target cells in the mixture. The result belongs to those conditions: target type, labeling, staining, time, ratio, and controls. The method paper describes an experimental readout. It does not make that readout a prediction of how a patient will respond to a treatment.

The readouts answer different questions

Swipe or scroll to read the full table →

Readout What it measures in the assay What it does not show by itself
CD107a surface signal after stimulation Granule release, or degranulation, by NK cells That target cells are being killed
K562 target-cell lysis with CFSE and dead-cell staining Death of labeled target cells under the assay conditions That a person will respond to a treatment or has a particular clinical outcome
Chromium release Release of label from dying target cells The same information as CD107a, or a general measure of immune strength

Why the readouts cannot be swapped

An example from inherited immune disease makes the distinction concrete. The study RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis used several functional measurements, including CD107a, K562-based tests, and chromium release. Chromium release is a target-cell lysis readout: labeled target cells release the label when they die. CD107a is a degranulation readout. They can both be called functional measures, but they do not carry the same information. The RhoG study is also a reminder of context. It concerns a rare genetic disorder and a severe inflammatory condition, hemophagocytic lymphohistiocytosis. Its findings do not establish how a routine NK activity result should be interpreted in a general health check.

What to look for in an NK cell activity result

If a report says NK cell activity, the first useful question is: activity measured how? A CD107a percentage and a target-cell lysis percentage are not two versions of one number. They come from different assay questions. A useful report should make the readout visible: whether it is degranulation, cytokine production, or target-cell killing; what target cell or stimulus was used; what controls were included; and what effector-to-target ratios were tested. Those details are not decorative. They define the measurement. Without them, a number such as NK activity is too vague to compare with another result.

What the distinction does not mean

None of this makes one readout better in the abstract. Degranulation, cytokine production, and target-cell lysis answer different laboratory questions. A killing assay may be the right readout for a question about target-cell death; a CD107a assay may be the right readout for a question about granule release. The mistake is to treat one as a proxy for the other without saying so. A method paper can show that an assay measures what it measures. It cannot show that a result predicts a clinical outcome. That step requires separate evidence in the relevant disease and use case.

The short answer

NK cell activity is measured with functional assays, and the result is only as specific as the readout. CD107a reports degranulation. K562 or other target-cell assays report target-cell death under defined conditions. Chromium release is another lysis readout. These measurements can complement one another, but they are not interchangeable. When you see an NK cell activity test, identify the readout before interpreting the number.

Educational note: This is general information about laboratory measurement, not a diagnosis or an interpretation of an individual result.

Sources and further reading

Keep reading

Follow the next question.

Tests & terms